- Home
- BMEA vs NTIC Comparison
BMEA vs NTIC Comparison
Compare BMEA & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- NTIC
- Stock Information
- Founded
- BMEA 2017
- NTIC 1970
- Country
- BMEA United States
- NTIC United States
- Employees
- BMEA N/A
- NTIC N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- NTIC Industrial Specialties
- Sector
- BMEA Health Care
- NTIC Industrials
- Exchange
- BMEA Nasdaq
- NTIC Nasdaq
- Market Cap
- BMEA 125.4M
- NTIC 105.9M
- IPO Year
- BMEA 2021
- NTIC N/A
- Fundamental
- Price
- BMEA $2.00
- NTIC $10.43
- Analyst Decision
- BMEA Buy
- NTIC Buy
- Analyst Count
- BMEA 13
- NTIC 1
- Target Price
- BMEA $27.92
- NTIC $20.00
- AVG Volume (30 Days)
- BMEA 636.9K
- NTIC 18.8K
- Earning Date
- BMEA 05-01-2025
- NTIC 04-10-2025
- Dividend Yield
- BMEA N/A
- NTIC 2.69%
- EPS Growth
- BMEA N/A
- NTIC 52.91
- EPS
- BMEA N/A
- NTIC 0.52
- Revenue
- BMEA N/A
- NTIC $86,216,235.00
- Revenue This Year
- BMEA $191.34
- NTIC $8.16
- Revenue Next Year
- BMEA N/A
- NTIC $10.97
- P/E Ratio
- BMEA N/A
- NTIC $20.03
- Revenue Growth
- BMEA N/A
- NTIC 7.59
- 52 Week Low
- BMEA $1.94
- NTIC $10.40
- 52 Week High
- BMEA $14.43
- NTIC $19.63
- Technical
- Relative Strength Index (RSI)
- BMEA 28.47
- NTIC 29.93
- Support Level
- BMEA $2.27
- NTIC $11.00
- Resistance Level
- BMEA $3.08
- NTIC $11.32
- Average True Range (ATR)
- BMEA 0.23
- NTIC 0.27
- MACD
- BMEA 0.00
- NTIC -0.05
- Stochastic Oscillator
- BMEA 2.95
- NTIC 2.50
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.